View Item 

Show simple item record

How I manage cold agglutinins
dc.contributor.authorJudd, W. Johnen_US
dc.date.accessioned2010-06-01T18:15:49Z
dc.date.available2010-06-01T18:15:49Z
dc.date.issued2006-03en_US
dc.identifier.citationJudd, W. John (2006). "How I manage cold agglutinins." Transfusion 46(3): 324-326. <http://hdl.handle.net/2027.42/71474>en_US
dc.identifier.issn0041-1132en_US
dc.identifier.issn1537-2995en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71474
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16533272&dopt=citationen_US
dc.format.extent50187 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights2006 Blackwell Publishing Ltden_US
dc.titleHow I manage cold agglutininsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid16533272en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71474/1/j.1537-2995.2006.00726.x.pdf
dc.identifier.doi10.1111/j.1537-2995.2006.00726.xen_US
dc.identifier.sourceTransfusionen_US
dc.identifier.citedreferenceGarratty G. The significance of complement in immuno-hematology. CRC Crit Rev Clin Lab Sci 1984; 20: 25 - 56.en_US
dc.identifier.citedreferenceNance SJ, Garratty G. A new potentiator of red blood cell antigen-antibody reactions. Am J Clin Pathol 1987; 87: 633 - 5.en_US
dc.identifier.citedreferenceLapierre Y, Rigal D, Adam J, et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990; 30: 109 - 13.en_US
dc.identifier.citedreferenceTrudeau LR, Judd WJ, Butch SH, Oberman HA. Is a room temperature crossmatch necessary for the detection of ABO errors? Transfusion 1983; 23: 237 - 9.en_US
dc.identifier.citedreferenceLaferriere M, Harrison L, Zack S. Parallel comparison of reading antiglobulin (AHG) phase microscopically vs. macroscopically in routine antibody screening [abstract]. Transfusion 1993; 33 ( Suppl ): 83.en_US
dc.identifier.citedreferenceJudd WJ, Steiner EA, Oberman HA, Nance SJ. Can the reading for serological reactivity following 37°C incubation be omitted? Transfusion 1992; 32: 304 - 8.en_US
dc.identifier.citedreferenceJudd WJ, Fullen DR, Steiner EA, Knafl PC, Davenport RD. Revisiting the issue: can the reading for serologic reactivity following 37°C incubation be omitted? Transfusion 1999; 39: 295 - 9.en_US
dc.identifier.citedreferenceJudd WJ, Steiner EA, Knafl PC. The gel test: sensitivity and specificity for unexpected antibodies to blood group antigens. Immunohematology 1997; 13: 132 - 5.en_US
dc.identifier.citedreferenceJudd WJ. Modern approaches to pretransfusion testing. Immunohematology 1999; 15: 41 - 52.en_US
dc.identifier.citedreferenceJudd WJ. Prewarmed tests: con. Transfusion 1995; 35: 271 - 5.en_US
dc.identifier.citedreferenceJudd WJ. Attack on prewarmed tests—too much hot air [letter]. Transfusion 1996; 36: 192 - 3.en_US
dc.identifier.citedreferenceJudd WJ, Steiner EA, Knafl P, Davenport RD. Failure to detect potentially significant antibodies in prewarmed tests. Transfusion 1995; 35 ( Suppl ): 68.en_US
dc.identifier.citedreferenceLeger RM, Garratty G. Weakening or loss of antibody reactivity after prewarm technique. Transfusion 2003; 43: 1611 - 4.en_US
dc.identifier.citedreferenceBeattie KM, Zuelzer WW. The frequency and properties of pH dependent anti-M. Transfusion 1965; 5: 322 - 3.en_US
dc.identifier.citedreferenceCronin CA, Pohl BA, Miller WV. Crossmatch compatible blood for patients with anti-P1. Transfusion 1978; 18: 728 - 30.en_US
dc.identifier.citedreferenceJudd WJ, Rolih SD, Dahr W, et al. Studies on the blood of an MsHe / MS u proposita and her family: serological evidence that Henshaw-producing genes do not code for “N.” Transfusion 1983; 23: 382 - 6.en_US
dc.identifier.citedreferenceJudd WJ. On the recognition of N-deficient red blood cells and the selection of blood for transfusion to patients with anti-N [editorial]. Immunohematology 1986; 2: 50 - 3.en_US
dc.identifier.citedreferenceButch SH, Judd WJ, Steiner EA, Stoe M, Oberman HA. Electronic verification of donor-recipient compatibility: the computer crossmatch. Transfusion 1994; 34: 105 - 9.en_US
dc.identifier.citedreferencePetz LD, Swisher SN, Kleinman S, Spence RE, Strauss RG, editors. Clinical practice of transfusion medicine. New York: Churchill Livingstone; 1996.en_US
dc.identifier.citedreferenceChaplin H, Hunter VL, Malecek AC, Kilzer P, Rosche ME. Clinical significance of allo-anti-I in an I-negative patient with massive hemorrhage. Transfusion 1986; 26: 57 - 61.en_US
dc.identifier.citedreferencePostoway N, Anstee DJ, Wortman M, Garratty G. A severe transfusion reaction associated with anti-En a TS in a patient with an abnormal alpha-like red cell sialoglycoprotein. Transfusion 1988; 28: 77 - 80.en_US
dc.identifier.citedreferenceDiaz JH, Cooper ES, Oschner JL. Cold agglutinin pathophysiology: evaluation and management of patients undergoing cardiac surgery with induced hypothermia. Arch Int Med 1984; 144: 1639 - 41.en_US
dc.identifier.citedreferenceGokhale AG, Suhastru T, Saraswati VM, Chandrasekhar N, Rajagopal P. Cold agglutinins and warm heart surgery. J Thorac Cardiovasc Surg 1993; 105: 557.en_US
dc.identifier.citedreferenceHolman WL, Smith SH, Edwards R, Huang ST. Agglutination of blood cardioplegia by cold reacting autoantibodies. Ann Thorac Surg 1991; 51: 833 - 6.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1537-2995.2006.00726.x.pdf
Size:
49.01KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.